NO991948D0 - Multi-funksjonelle, chimeriske hematopoietiske reseptorantagonister - Google Patents

Multi-funksjonelle, chimeriske hematopoietiske reseptorantagonister

Info

Publication number
NO991948D0
NO991948D0 NO991948A NO991948A NO991948D0 NO 991948 D0 NO991948 D0 NO 991948D0 NO 991948 A NO991948 A NO 991948A NO 991948 A NO991948 A NO 991948A NO 991948 D0 NO991948 D0 NO 991948D0
Authority
NO
Norway
Prior art keywords
functional
receptor antagonists
hematopoietic receptor
chimeric hematopoietic
chimeric
Prior art date
Application number
NO991948A
Other languages
English (en)
Other versions
NO991948L (no
Inventor
Charles A Mcwherter
Yiqing Feng
John P Mckearn
Neena L Summers
Nicholas R Staten
Philip R Streeter
John C Minnerly
Nancy I Minster
Susan L Woulfe
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of NO991948D0 publication Critical patent/NO991948D0/no
Publication of NO991948L publication Critical patent/NO991948L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO991948A 1996-10-25 1999-04-23 Multifunksjonelle kimere hematopoetiske reseptoragonister NO991948L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2962996P 1996-10-25 1996-10-25
PCT/US1997/020037 WO1998017810A2 (en) 1996-10-25 1997-10-23 Multi-functional chimeric hematopoietic receptor agonists

Publications (2)

Publication Number Publication Date
NO991948D0 true NO991948D0 (no) 1999-04-23
NO991948L NO991948L (no) 1999-06-23

Family

ID=21850035

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991948A NO991948L (no) 1996-10-25 1999-04-23 Multifunksjonelle kimere hematopoetiske reseptoragonister

Country Status (17)

Country Link
EP (1) EP0935663A2 (no)
JP (1) JP2001504689A (no)
KR (1) KR100497423B1 (no)
AR (1) AR010041A1 (no)
AU (1) AU725547B2 (no)
BR (1) BR9713668A (no)
CA (1) CA2268742A1 (no)
CZ (1) CZ295843B6 (no)
IL (1) IL129565A0 (no)
NO (1) NO991948L (no)
NZ (1) NZ335382A (no)
PL (1) PL333023A1 (no)
RO (1) RO120919B1 (no)
RU (2) RU2245887C2 (no)
TW (2) TW200413407A (no)
WO (1) WO1998017810A2 (no)
ZA (1) ZA979607B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5581476A (en) 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
PL336159A1 (en) * 1997-04-11 2000-06-05 Searle & Co Chimeric proteins incorporating the flt3
BR9905867A (pt) * 1998-11-06 2001-01-23 Bio Sidus S A Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula
WO2002101047A1 (en) * 2001-06-12 2002-12-19 Smithkline Beecham Corporation Method of identifying compounds that modulate epo primary response gene 1, eprg1, activities
BR0211071A (pt) 2001-07-11 2004-12-21 Maxygen Holdings Ltd Conjugado polipeptìdico apresentando atividade de g-csf, método para preparar um conjugado de g-csf, composição, método para tratar um mamìfero sofrendo de um nìvel neutrofìlico insuficiente, e, uso do conjugado polipeptìdico
WO2005047461A2 (en) 2003-08-18 2005-05-26 The Regents Of The University Of California Polypeptide display libraries and methods of making and using thereof
MX2007015156A (es) 2005-06-01 2008-02-15 Maxygen Holdings Ltd Polipeptidos g-csf pegilados y metodos para la produccion de los mismos.
US7550433B2 (en) * 2005-06-03 2009-06-23 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
EP3181575B1 (en) 2005-08-31 2021-03-17 The Regents of The University of California Cellular libraries of peptide sequences (clips) and methods of using the same
WO2007098548A1 (en) * 2006-03-01 2007-09-07 Apollo Life Sciences Limited A molecule and chimeric molecules thereof
WO2009014726A1 (en) 2007-07-26 2009-01-29 The Regents Of The University Of California Methods for enhancing bacterial cell display of proteins and peptides
US10071109B2 (en) 2013-11-06 2018-09-11 Molecular Templates, Inc. Predictive biomarker for hypoxia-activated prodrug therapy
CA3133830A1 (en) * 2019-03-28 2020-10-01 Orionis Biosciences, Inc. Fms-like tyrosine kinase 3 ligand (flt3l)-based chimeric proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0503050A4 (en) * 1990-09-28 1994-07-06 Ortho Pharma Corp Hybrid growth factors
US5376367A (en) * 1991-11-22 1994-12-27 Immunex Corporation Fusion proteins comprising MGF and IL-3
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US5635599A (en) * 1994-04-08 1997-06-03 The United States Of America As Represented By The Department Of Health And Human Services Fusion proteins comprising circularly permuted ligands

Also Published As

Publication number Publication date
CZ132399A3 (cs) 1999-12-15
EP0935663A2 (en) 1999-08-18
NZ335382A (en) 2001-03-30
RO120919B1 (ro) 2006-09-29
BR9713668A (pt) 2000-03-08
AU5165298A (en) 1998-05-15
RU2005105360A (ru) 2006-08-10
WO1998017810A2 (en) 1998-04-30
AR010041A1 (es) 2000-05-17
TW200413407A (en) 2004-08-01
KR100497423B1 (ko) 2005-07-07
TW591035B (en) 2004-06-11
CZ295843B6 (cs) 2005-11-16
NO991948L (no) 1999-06-23
CA2268742A1 (en) 1998-04-30
RU2245887C2 (ru) 2005-02-10
JP2001504689A (ja) 2001-04-10
WO1998017810A3 (en) 1998-10-15
KR20000052812A (ko) 2000-08-25
PL333023A1 (en) 1999-11-08
AU725547B2 (en) 2000-10-12
ZA979607B (en) 1999-04-28
IL129565A0 (en) 2000-02-29

Similar Documents

Publication Publication Date Title
DE69734833D1 (de) Vitronektin rezeptor antagonisten
DE69812096T2 (de) Neuropeptid y rezeptorantagonisten
TR199801594A3 (tr) CCR-3 reseptör antagonistleri.
ATE280157T1 (de) 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
ATE233260T1 (de) Muscarin-antagonisten
NO20012411D0 (no) Pyrrolidin-derivater-CCR-3-reseptorantagonister
NO972016D0 (no) Indolyl-Y-reseptorantagonister
DK1009732T3 (da) 1-Amino-alkylcyclohexan NMDA receptor antagonister
ATE272632T1 (de) Muskarin-rezeptor antagonisten
ID24726A (id) Antagonis-antagonis reseptor trombin
NO991948D0 (no) Multi-funksjonelle, chimeriske hematopoietiske reseptorantagonister
ID24162A (id) Antagonis-antagonis reseptor vitronektin
DK0906294T3 (da) Benzoxazinon-dopamin D4-receptor-antagonister
BR9707733A (pt) Antagonistas de receptores muscarinicos oxa-e-tia-diazol
BR9507220A (pt) Antagonistas de receptores de endotelina
NO981500D0 (no) Multi-funksjonelle hematopoetiske reseptor antagonister
RU99111071A (ru) Многофункциональные химерные агонисты гемопоэтических рецепторов
DZ2322A1 (fr) Antagonistes de récepteurs de vitronectine.
TR199501389A2 (tr) Adesyon reseptörü antagonistleri (karsitlari).
AU1296899A (en) Phenyl-alkyl-imidazoles as h3 receptor antagonists
DE69735811D1 (de) Piperazinoderivate als neurokinin-antagonisten
ITVR970052A0 (it) Manufatto impermeabilizzante per uso edile
TR199601082A3 (tr) Entegrin reseptör antagonistleri.
ZA986551B (en) Endothelin receptor antagonists.
ZA200003475B (en) Muscarinic receptor antagonists.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application